AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8282360 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg fosinopril plus 12.5 mg hydrochlorothiazide
Number of subjects: 67
Study 8282360 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg fosinopril
Number of subjects: 67
Study 8282360 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg hydrochlorothiazide
Number of subjects: 67
Study 8282360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 2662389 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate suspension 1 g in 5 ml qid
Number of subjects: 49
Study 2662389 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg bid
Number of subjects: 49
Study 29628483 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate 0.1 mg/day
Number of subjects: 526
Study 29628483 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate 0.2 mg/day
Number of subjects: 526
Study 29628483 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate 0.4 mg/day
Number of subjects: 526
Study 29628483 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 100 mg/day
Number of subjects: 526
Study 29628483 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg/day
Number of subjects: 526
Study 29628483 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 526
Study 27886619 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 150mg every 2 weeks (Q2W)
Number of subjects: 58
Study 25256901 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years Parenting Programme (IYPP)
Number of subjects: 28
Study 22766394 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg single dose)
Number of subjects: 3
Study 22766394 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy controls)
Number of subjects: 3
Study 22766394 — intervention group
Group type: COMPARATOR
Intervention: Control (MS patients without fatigue)
Number of subjects: 3
Study 21901116 — intervention group
Group type: EXPERIMENTAL
Intervention: HealthyDiet group (whole grain and low postprandial insulin response grain products, fatty fish three times a week, and bilberries three portions per day)
Number of subjects: 106
Study 21901116 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain enriched diet (WGED) group
Number of subjects: 106
Study 21901116 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat breads (Control)
Number of subjects: 106
Study 18331816 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC) monotherapy
Number of subjects: 147
Study 16880102 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pulmonary hypertension (PHTN)
Number of subjects: 79
Study 16880102 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery systolic pressure
Number of subjects: 79
Study 12611748 — intervention group
Group type: EXPERIMENTAL
Intervention: HL 2 mg-3 mg/day (standard dose)
Number of subjects: 71
Study 12611748 — intervention group
Group type: EXPERIMENTAL
Intervention: HL 0.5 mg-0.75 mg/day (low dose)
Number of subjects: 71
Study 12611748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 12611748 — intervention group
Group type: EXPERIMENTAL
Intervention: HL plasma levels
Number of subjects: 71
Study 11317829 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral gatifloxacin 400 mg once daily
Number of subjects: 17923
Study 9174486 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g n-3 ethyl esters three times a day for 2 months
Number of subjects: 935
Study 9174486 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g n-3 ethyl esters twice a day for 4 months
Number of subjects: 935
Study 9174486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 935
Study 9174486 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 ethyl esters
Number of subjects: 935
Study 7504142 — intervention group
Group type: EXPERIMENTAL
Intervention: xamoterol
Number of subjects: 40
Study 7504142 — intervention group
Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 40
Study 31659983 — intervention group
Group type: COMPARATOR
Intervention: Overweight (BMI 25 ≤BMI <30)
Number of subjects: 22922
Study 31659983 — intervention group
Group type: COMPARATOR
Intervention: Class I obesity (BMI 30 ≤BMI <35)
Number of subjects: 22922
Study 31659983 — intervention group
Group type: EXPERIMENTAL
Intervention: Class III obesity (BMI ≥40)
Number of subjects: 22922
Study 31659983 — intervention group
Group type: EXPERIMENTAL
Intervention: Class II obesity (BMI 35 ≤BMI <40)
Number of subjects: 22922
Study 31659983 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity (all classes)
Number of subjects: 22922
Study 31563388 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS treatment
Number of subjects: 16
Study 31563388 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 16
Study 29208832 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IOL
Number of subjects: 137
Study 29208832 — intervention group
Group type: COMPARATOR
Intervention: Acriol EC IOL
Number of subjects: 137
Study 25946503 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized auriculotherapy (G3)
Number of subjects: 175
Study 25946503 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol auriculotherapy (G2)
Number of subjects: 175
Study 25946503 — intervention group
Group type: COMPARATOR
Intervention: Control group (G1)
Number of subjects: 175
Study 24043277 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery Room (DR) intubation during/after SUPPORT trial
Number of subjects: 3527
Study 24043277 — intervention group
Group type: COMPARATOR
Intervention: Delivery Room (DR) intubation at PMH
Number of subjects: 3527
Study 21169815 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg 12 hours before PCI, plus 40 mg preprocedure)
Number of subjects: 81
Study 21169815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 19665835 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed patients (CESD positive)
Number of subjects: 391
Study 19665835 — intervention group
Group type: COMPARATOR
Intervention: Non-depressed patients (CESD negative)
Number of subjects: 391
Study 19665835 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms (measured by CESD)
Number of subjects: 391
Study 16910475 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane with 0.6 mg x kg(‐1) Org 9426
Number of subjects: 38
Study 16910475 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with 0.6 mg x kg(‐1) Org 9426
Number of subjects: 38
Study 16910475 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane with 0.9 mg x kg(‐1) Org 9426
Number of subjects: 38
Study 16910475 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with 0.9 mg x kg(‐1) Org 9426
Number of subjects: 38
Study 16910475 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (both doses)
Number of subjects: 38
Study 16910475 — intervention group
Group type: COMPARATOR
Intervention: Propofol (both doses)
Number of subjects: 38
Study 16910475 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 mg x kg(‐1) Org 9426
Number of subjects: 38
Study 16910475 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane and Propofol
Number of subjects: 38
Study 15479777 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (>30 mg/kg) rectally administered acetaminophen
Number of subjects: 10
Study 15479777 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 10
Study 11320559 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic fields exposure in locomotive drivers
Number of subjects: 48
Study 11320559 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic fields exposure in persons working with monitors
Number of subjects: 48
Study 11320559 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study 9134651 — intervention group
Group type: EXPERIMENTAL
Intervention: PAI-1 activity in stroke patients (n = 245) at presentation (11.6 U/ml) and after three months (11.8 U/ml)
Number of subjects: 558
Study 9134651 — intervention group
Group type: EXPERIMENTAL
Intervention: PAI-1 activity
Number of subjects: 558
Study 9134651 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 558
Study 8185448 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised training (12 weeks, 45 minutes duration, two sessions per week)
Number of subjects: 69
Study 8185448 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise group (usual care program)
Number of subjects: 69
Study 8185448 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised training
Number of subjects: 69
Study 8185448 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise group
Number of subjects: 69
Study 2889501 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphasalazine (SASP)
Number of subjects: 26
Study 2889501 — intervention group
Group type: COMPARATOR
Intervention: D‐penicillamine (DPA)
Number of subjects: 26
Study 31400231 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 g/kg IgPro20
Number of subjects: 172
Study 31400231 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 g/kg IgPro20
Number of subjects: 172
Study 31400231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 29903026 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell transplantation (MSCT)
Number of subjects: 105
Study 29903026 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional medication)
Number of subjects: 105
Study 26966819 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) during menstrual cycle
Number of subjects: 32
Study 26966819 — intervention group
Group type: COMPARATOR
Intervention: No kinesio taping (No-KT) during menstrual cycle
Number of subjects: 32
Study 24620041 — intervention group
Group type: EXPERIMENTAL
Intervention: L-protocol (lengthening exercises)
Number of subjects: 56
Study 24620041 — intervention group
Group type: COMPARATOR
Intervention: C-protocol (conventional exercises)
Number of subjects: 56
Study 23635343 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall Video Analysis Questionnaire (FVAQ)
Number of subjects: 130
Study 20723776 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophil major basic protein detection in nasal mucus
Number of subjects: 23
Study 20723776 — intervention group
Group type: COMPARATOR
Intervention: Control group (chronic rhinosinusitis-like symptoms without mucosal thickening, functional endoscopic sinus surgery for other reasons, and patients without sinus disease)
Number of subjects: 23
Study 18164064 — intervention group
Group type: COMPARATOR
Intervention: Laser Peripheral Iridotomy (LPI)
Number of subjects: 62
Study 18164064 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Phacoemulsification
Number of subjects: 62
Study 16877898 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 20
Study 16877898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 14582575 — intervention group
Group type: EXPERIMENTAL
Intervention: Family empowerment intervention service for arrested youth
Number of subjects: 0
Study 14582575 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused early-intervention, intensive case management service for youth entering a diversion program
Number of subjects: 0
Study 14582575 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive program of research and program development at Miami-Dade Juvenile Assessment Center
Number of subjects: 0
Study 11049951 — intervention group
Group type: EXPERIMENTAL
Intervention: Peribulbar LA with balloon compression (group A)
Number of subjects: 30
Study 11049951 — intervention group
Group type: COMPARATOR
Intervention: Peribulbar LA alone (group B, control)
Number of subjects: 30
Study 11049951 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival LA (group C)
Number of subjects: 30
Study 9054044 — intervention group
Group type: EXPERIMENTAL
Intervention: Obsidian
Number of subjects: 0
Study 9054044 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 0
Study 9054044 — intervention group
Group type: COMPARATOR
Intervention: Reserpin
Number of subjects: 0
Study 9054044 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam plus Reserpin
Number of subjects: 0
Study 1353654 — intervention group
Group type: EXPERIMENTAL
Intervention: CODETRON (acupuncture-like stimulation)
Number of subjects: 0
Study 1353654 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 6515723 — intervention group
Group type: EXPERIMENTAL
Intervention: Check-up group (annual chest X-ray and bacteriological examination)
Number of subjects: 15000
Study 6515723 — intervention group
Group type: COMPARATOR
Intervention: Discharge group (no annual check-ups, encouraged to report symptoms)
Number of subjects: 15000
Study 30058061 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular 8mg lornoxicam (Group 1, n=27)
Number of subjects: 51
Study 30058061 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 8mg lornoxicam (Group 2, n=24)
Number of subjects: 51
Study 30058061 — intervention group
Group type: EXPERIMENTAL
Intervention: Total (both groups combined)
Number of subjects: 51
Study 30058061 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Group 1 and Group 2
Number of subjects: 51
Study 29018954 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutaneous plantar anaesthesia (lidocaine injection at the centre of forefoot, lateral midfoot, and heel)
Number of subjects: 30
Study 29018954 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 26142713 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrance Kegel Device (VKD) with pelvic floor muscle exercises (PFMEs)
Number of subjects: 40
Study 26142713 — intervention group
Group type: COMPARATOR
Intervention: PFMEs alone (Control)
Number of subjects: 40
Study 24412896 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention for physical activity and diet
Number of subjects: 434
Study 23045542 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN)
Number of subjects: 438
Study 23045542 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 438
Study 19398614 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intervention consisting of eighteen 30‐minute lessons delivered twice weekly for 9 weeks, focusing on teaching critical emergent literacy skills within small groups.
Number of subjects: 220
Study 19398614 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (control group).
Number of subjects: 220
Study 17559758 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUS followed by ablation (L-A)
Number of subjects: 0
Study 17559758 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUS followed by hysterectomy (L-H)
Number of subjects: 0
Study 17559758 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal balloon endometrial ablation (TBEA)
Number of subjects: 0
Study 17559758 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave endometrial ablation (MEA)
Number of subjects: 0
Study 17559758 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 0
Study 14701889 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic spinal manipulation (3 sessions)
Number of subjects: 201
Study 14701889 — intervention group
Group type: COMPARATOR
Intervention: Usual GP care
Number of subjects: 201
Study 10773176 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 0
Study 10773176 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotropic drugs
Number of subjects: 0
Study 9312195 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate
Number of subjects: 27
Study 9312195 — intervention group
Group type: COMPARATOR
Intervention: Calcium
Number of subjects: 27
Study 8396177 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% minocycline ointment
Number of subjects: 103
Study 8396177 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 103
Study 2426069 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (COF regimen: Vincristine 1 mg, cyclophosphamide 600 mg, 5-fluorouracil 500 mg IV on days 1 and 8, with or without Pingyangmycin 10 mg IM on days 1, 3, 6, and 8)
Number of subjects: 25
Study 2426069 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 25
Study 30673004 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise therapy with a single supervised session (Group A)
Number of subjects: 30
Study 30673004 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise therapy with weekly supervision (Group B)
Number of subjects: 30
Study 30673004 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Group A and Group B
Number of subjects: 30
Study 26825650 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of epidermal growth factor (EGF)
Number of subjects: 97
Study 26825650 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (observation)
Number of subjects: 97
Study 24738648 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai traditional massage (TTM)
Number of subjects: 72
Study 24738648 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound
Number of subjects: 72
Study 22796513 — intervention group
Group type: EXPERIMENTAL
Intervention: New Clinical Pathway (NCP)
Number of subjects: 1570
Study 22796513 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 1570
Study 20423624 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (exposed to the reminiscence program)
Number of subjects: 90
Study 20423624 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 20423624 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control group
Number of subjects: 90
Study 17443645 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral leuprolide
Number of subjects: 52
Study 17443645 — intervention group
Group type: COMPARATOR
Intervention: Oral bicalutamide
Number of subjects: 52
Study 17443645 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (leuprolide and bicalutamide)
Number of subjects: 52
Study 15886663 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic calf and foot compression (IPCFC) applied for 1 hour twice daily in the sitting position, along with daily exercise.
Number of subjects: 30
Study 15886663 — intervention group
Group type: COMPARATOR
Intervention: Control group advised exercise alone.
Number of subjects: 30
Study 12562884 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supervised brushing with fluoride toothpaste
Number of subjects: 273
Study 12562884 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 273
Study 11084786 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (3 mg bolus) with K(+)-enriched cardioplegia
Number of subjects: 68
Study 11084786 — intervention group
Group type: COMPARATOR
Intervention: K(+)-enriched cardioplegia without adenosine
Number of subjects: 68
Study 8804870 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily
Number of subjects: 158
Study 8804870 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg twice daily
Number of subjects: 158
Study 1986632 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser (group I, 10 subjects)
Number of subjects: 21
Study 1986632 — intervention group
Group type: COMPARATOR
Intervention: Microscissors (group II, 11 subjects)
Number of subjects: 21
Study 6628792 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% DNCB ointment for 2 days followed by 0.05% DNCB ointment daily (group I)
Number of subjects: 73
Study 6628792 — intervention group
Group type: COMPARATOR
Intervention: 0.05% DNCB preparation only (group II)
Number of subjects: 73
Study 29631974 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT) plus quadriceps strengthening exercise
Number of subjects: 32
Study 29631974 — intervention group
Group type: COMPARATOR
Intervention: Placebo technique plus quadriceps strengthening exercise
Number of subjects: 32
Study 30685301 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 100
Study 30685301 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 100
Study 30685301 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine vs Phenylephrine
Number of subjects: 100
Study 30384885 — intervention group
Group type: EXPERIMENTAL
Intervention: Control of 4 to 6 risk factors
Number of subjects: 2102
Study 30384885 — intervention group
Group type: COMPARATOR
Intervention: Control of 0 to 1 risk factor
Number of subjects: 2102
Study 30384885 — intervention group
Group type: EXPERIMENTAL
Intervention: Being a nonsmoker, regular physical activity, systolic blood pressure <130 mm Hg, following the American Heart Association Step 2 diet
Number of subjects: 2102
Study 27044332 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 250
Study 27044332 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 250
Study 24990907 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 0
Study 24990907 — intervention group
Group type: COMPARATOR
Intervention: PCV7
Number of subjects: 0
Study 22313275 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Silorane Restorative System (FS)
Number of subjects: 25
Study 22313275 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Scotchbond 1 XT with Filtek Z250 (XT)
Number of subjects: 25
Study 22313275 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Scotchbond SE with Filtek Z250 (SE)
Number of subjects: 25
Study 20464985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention treatment group (systemic patient management including patient education, regular telephone interviews, physician-patient communication)
Number of subjects: 230
Study 20464985 — intervention group
Group type: COMPARATOR
Intervention: General treatment group (normal clinical procedure)
Number of subjects: 230
Study 20464985 — intervention group
Group type: COMPARATOR
Intervention: General treatment group
Number of subjects: 230
Study 20464985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention treatment group
Number of subjects: 230